Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Small cap wrap: Highland Critical Minerals, TNR Gold, Altius Minerals Corporation...

The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,331.30, down 85.60 points or 2.51% on Thursday as we launched into the Easter weekend, while remaining up 27.00 points or 0.82% over the past 5 trading days.

As the market fluctuates, small-cap companies continue to update the market. Today, so far, we've seen executive appointments, project ownership and exploration progress. You can read about the following and more throughout the day.

Read more

Lindian Resources Ltd (ASX:LIN, OTC:LINIF) has bolstered its executive team with the appointment of experienced mining finance leader Derek Bideshi as chief financial officer, as the company moves closer to production at its flagship Kangankunde rare earths project in Malawi.

The appointment comes at a pivotal stage for Lindian, with construction under way at Kangankunde and parallel efforts advancing its downstream processing strategy through SARECO, positioning the company as an emerging integrated rare earths producer.

Read more

TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) said on Monday it has entered into a private placement agreement with Altius Resources, a wholly-owned subsidiary of Altius Minerals Corporation (TSX:ALS, OTCQX:ATUSF), for gross proceeds of approximately C$4.2 million.

As part of the agreement, Altius Resources will subscribe for 23.5 million common shares of TNR Gold, representing about 9.9% of the company’s outstanding shares on a post-issuance basis. The shares are priced at C$0.1775 each, based on the 30-day volume-weighted average price prior to the agreement dated April 2.

Read more

Medicus Pharma (NASDAQ:MDCX) announced on Monday that it has submitted an optimized Phase 2 clinical study protocol to the US Food and Drug Administration (FDA) for Teverelix, an investigational GnRH antagonist.

The study is designed to evaluate the drug's effectiveness in preventing recurrent acute urinary retention (AURr) in men with benign prostatic hyperplasia (BPH) as part of an existing open Investigational New Drug application.

Read more

Highland Critical Minerals Corp (CSE:HLND, FRA:U8X) announced it has completed a non-brokered flow-through private placement, raising gross proceeds of C$400,000 through the issuance of 1.6 million common shares.

The shares were issued at a price of C$0.25 each and qualify as “flow-through shares” under Canada’s Income Tax Act, allowing investors to benefit from certain tax deductions tied to eligible exploration spending.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK